Search: 2018 EU Meeting Faculty
Results 41 - 57 of 57

Jan Seal-Roberts

Publishing Director
Adis, Springer Healthcare


Type of Company:
Publisher
Professional Degrees: BA/BS

Bio: Jan Seal-Roberts is a medical publisher with more than 20 years of experience, having worked with several global companies, including Blackwell Science (now part of Wiley), Wolters Kluwer and Springer Nature. Jan is currently Publishing Director for Adis (part of Springer Nature) which publishes around 35 journals, including both subscription-based and OA titles, exclusively in the area of drugs and disease management.

Danielle Sheard

Head of Publications, Publications
Costello Medical


Type of Company:
Communications Agency
Professional Degrees: BA/BS

Bio: Danielle is Head of Publications at Costello Medical, a consultancy that provides scientific support to the healthcare sector in the analysis, interpretation and communication of clinical and health economic data. Danielle started her career in medical communications after graduating from the University of Cambridge with a degree in Natural Sciences. She developed her writing and project management skills at the specialist healthcare publishing company MGP Ltd, through work on a variety of educational projects for healthcare professionals including working party guidelines and eLearning materials. Since joining Costello Medical, Danielle has managed and delivered global publications plans, manuscripts and congress publications across a range of disease areas. She is a member of ISMPP and has submitted her own research to the European meeting since 2015. Danielle is now responsible for managing the Publications Division at Costello, which involves overseeing all the ongoing publications work, continually improving processes and developing the team. She particularly enjoys advising clients and finding innovative solutions to publications challenges.

Rachel Sherman

Head of Operations
Fishawack Group


Type of Company:
Communications Agency
Professional Degrees: BA/BS, CMPP, PhD
CMPP Certified: (9/2010)

Bio: Rachel is a Certified Medical Publication Professional (ISMPP CMPPTM) with over 20 years' experience in research and medical communications. She gained her PhD in the metabolic programming of hypertension and has comprehensive medical communications experience in a number of different therapy areas including cardiovascular disease, diabetes, urology, haematology and psychiatry. Rachel has spent a significant proportion of her medical communications career based in the US, and has delivered a variety of medical education outputs for the US domestic, as well as global and European, markets. She has also worked on a secondment basis within pharmaceutical companies providing on-site publication management support to clients. Rachel has a leadership role across the Fishawack organization, and specializes in delivering scientific engagement and publication projects. She provides technical and strategic expertise, and directs the delivery of a range of medical communication services, taking responsibility for client service and quality of deliverables. She is also co-chair on the ISMPP credentialing committee.

Richard Smith

Chair
Patients Know Best


Bio: Richard Smith is chair of the board of trustees of icddr,b (formerly the International Centre for Diarrhoeal Disease Research, Bangladesh) and chair of Patients Know Best (a company that brings all medical and social care records together in one place under the control of patients). From 2004 to 2015 he was the director of the UnitedHealth Chronic Disease Initiative. From 1979 to 2004 he worked at the BMJ and was the editor of the journal and chief executive of the BMJ Publishing Group from 1991 until he left. A member of the board of the Public Library of Science from 2004 to 2011, he continues to blog for the BMJ and to publish regularly. He is an adjunct professor at Imperial College Institute of Global Health Innovation. Having qualified in medicine in Edinburgh in 1976, Smith worked in hospitals in Scotland and New Zealand before joining the BMJ. He also worked for six years as a television doctor with the BBC and TV-AM and has a degree in management science from the Stanford Business School. He was made a Commander of the British Empire in 2000.

Stuart Spencer

Sr. Executive Editor
The Lancet


Bio: Stuart joined The Lancet in 1999 and throughout his time there has led the Fast Track team that aims to select, review and publish prestigious manuscripts within 4 weeks of receipt. Although dealing with all areas of research, he deals with most of the cardiology submissions. After graduating Stuart moved into research which started at the Brompton Hospital, London, looking at scoliosis in children before moving to the Veterinary School site at Bristol University. During this period he was invited to establish a research unit in The Netherlands. Later he set up a research team for a major pharmaceutical company in Switzerland for a year, and then spent 9 years as a senior researcher in New Zealand. He has also had two senior research fellowships at Leuven University, Belgium, and visiting professorships at Kings College, London and Hong Kong University, and a doctorate of medicine from Umea University, Sweden. Stuarts research expertise includes such diverse topics as, growth, neuroendocrinology, immunology and fetal development . He also had a Senior Fellowship in bioethics for 5 years. This broad research base in front-line research has given a clear understanding of principles in research and publications applicable across disciplines. Stuart is also a Trustee of the Scoliosis Association (UK), is on the British Scoliosis Research Fund grants committee and the Steering Committee of the Swedish National GP Research School.

Rafal Swierzewski

Expert, consultant
European Cancer Patient Coalition (ECPC)


Bio: Rafal Swierzewski has been involved in patient advocacy for ten years as both a scientist and cancer survivor. He earned his PhD in 2006 by examining the physical and chemical properties of model macromolecules (incl. new chemotherapy compounds) in cellular environment. From 2013 to 2016 he served as Board Member of the European Cancer Patient Coalition (ECPC). From 2013 he represents ECPC in patients' and Consumers' Working Party within the European Medicines Agency (EMA). Through the EMA, he is involved in various projects, such as Adaptive Pathways, IMI-ADVANCE (member of Scientific Advisory Board) and IMI-WEBRADR, IMI-PREFER. Rafal also represents patients' interests in the European Unions clinical trial portal and database of stakeholder groups created within the EMA to construct new systems for implementing European regulations on clinical trials and clinical data. Recently Rafal has been appointed as a member of Technical Anonymization Group (TAG) created by the EMA to continue the work undertaken during the development and finalisation of the external guidance on the anonymization of clinical reports for publication.

Russell Traynor

Director, Platform Strategy, Envision Technology Solutions
Envision Pharma Group


Type of Company:
Technology Provider
Professional Degrees: BA/BS, CMPP, MS
Other Degrees*: MSc
CMPP Certified: (2/2009)

Bio: Russell Traynor is iEnvision Strategy Lead, Envision Technology Solutions, responsible for working with his clients to identify and implement effective technology solutions to meet their needs. Russell has worked in medical communications and publications since 1997, both as a medical writer, account lead and business consultant. Russell has presented and published extensively in the area of medical publications, including topics such as Open Access Publishing, need for Quality Control globally, successful implementation of one SOP across the organization, and the future of medical publications. Russell has served on ISMPPs Board of Trustee as European Trustee and the Chairman of ISMPP, 2012-2013. He is an ISMPP Certified Medical Publication Professional (CMPP).

Katherine Tucker

Senior Manager - Data Sharing Lead
Roche Products Ltd.


Bio: Katherine has over twenty years experience in the pharmaceutical industry. Her background is a clinical trial statistician at Pfizer, Roche and Novartis. After several years as a statistical programming manager at Roche, since 2013 she has led a team at Roche dedicated to patient-level data sharing. She was part of the original GSK/Roche collaboration which led to the creation of ClinicalStudyDataRequest.com (CSDR) and continues to be involved with CSDR, EFSPI-PSI (European Federation of Statisticians in the Pharmaceutical Industry - Statisticians in the Pharmaceutical Industry) and PhUSE. Part of the remit of her team is to deliver on all data sharing requests originating from CSDR, support data de-identification activities across Roche and build internal data access processes and capabilities. She was part of the TransCelerate working group on data anonymization and was lead author of the EFSPI/PSI paper "Protecting patient privacy when sharing patient-level data from clinical trials." She is co-lead on a Roche project to address EMA policy 0070 requirements.

Steven Walker

Director and Co-Owner
St Gilesmedical London & Berlin


Type of Company:
Communications Agency
Professional Degrees: MD, MEd, MS
CMPP Certified: (3/2016)

Bio: Steven has degrees in medicine, education and clinical oncology. He trained in the UK, USA and Germany. His focus is on building St Gilesmedical's team of medics, scientists, writers and educators in London and Berlin into a major health communication company. Current interests include medical and regulatory writing, teaching and delivery of effective meetings. Steven is active in ISMPP, EMWA and lectures at Manchester Metropolitan University. St Gilesmedical also supports non-commercial education and research activities in the UK and Germany. The needs of patients and healthcare professionals are at the centre of everything we do.

Al Weigel

President/CEO
ISMPP

CMPP Certified: (2/2009)

Bio: Al Weigel is President and COO for the International Society for Medical Publication Professionals (ISMPP). Al joined ISMPP in November of 2013 with primary responsibility for implementing the strategic goals and vision of the Society, in addition to ensuring the Society meets established milestones for ongoing development, growth and success. Prior to joining ISMPP, Al led cross-therapeutic medical publication and scientific communication teams at sanofi-aventis, Boehringer-Ingelheim and Celgene Corporation. Al earned his Masters of Education at the University of the Arizona and currently is a ISMPP Certified Medical Publication Professional (CMPP).

Richard White

Commercial Director
Oxford PharmaGenesis Ltd


Type of Company:
Communications Agency
Professional Degrees: MA, PhD

Bio: Richard White is Commercial Director of Oxford PharmaGenesis, an independent HealthScience communications consultancy. He has more than 18 years of experience in medical communications, and has led launch publications plans for products across a broad range of therapy areas. Richard is a member of the International Society for Medical Publications Professionals (ISMPP), the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) and the Institute of Directors. He was a reviewer of the GPP2 and GPP3 guidelines, and has personally authored 17 publications in peer-reviewed journals. Richard has also published white papers on good publication practice, value demonstration and rare diseases in Pharmaceutical Marketing Europe, is an invited author of articles for ISMPP's MAP e-newsletter, and is on the Editorial Board of Drugs in Context. Richard founded the Oxford PharmaGenesis Value Demonstration Practice to apply good publication practice and communications expertise to HEOR, RWE and patient-reported outcomes (PRO) studies. He has run training workshops in these areas for multiple pharma companies and academic institutions, and has delivered invited presentations, educational webinars and moderated roundtable discussions on publications and communications best practice in HEOR, RWE and PROs at the ISMPP and TIPPA Annual Meetings. Richard was Chair of the 2017 TIPPA Annual Meeting. Before joining Oxford PharmaGenesis, Richard gained his MA and PhD in Natural Sciences from the University of Cambridge, UK. His PhD research won the 1998 Glaxo Wellcome Young Investigator's Award, and he was awarded a Research Fellowship in Pharmacology at Sidney Sussex College, Cambridge. He has completed the Advanced Health Economic Modeling Programme at the University of Oxford, is an alumnus of the International Marketing Programme at INSEAD, and is a member of Green Templeton College, University of Oxford, UK.

Witold Wiecek

Statistical Project Manager
Analytica Laser


Bio: Witold Wiecek, is a Statistical Project Manager at Analytica Laser, Witold is currently a technical lead for HOPE: LASER's proprietary tool for modelling real-world effectiveness, as well as working and publishing on Bayesian inference models, survival analysis, network meta-analyses, and infectious disease modelling.

Jurgen Wiehn

Director, Scientific Publications
Shire


Type of Company:
Pharmaceutical
Professional Degrees: CMPP, PhD
CMPP Certified: (9/2011)

Bio: Jurgen, PhD, ISMPP CMPP, has over 15 years of international pharmaceutical/biotech experience in medical affairs and clinical development (Publications/Scientific and Regulatory Writing; Medical Information, Communication and Education). Prior to industry career, Jurgen studied biology, gained his PhD in Finland and lead academic research programs in Finland and Switzerland. His industry experience comes from Orion Pharma, Merck Serono, Ferring Pharmaceuticals and, most recently, from Shire, where Jurgen works as a Director, Global Scientific Publications since 2011.

David Williams

Global engagement lead Real World Data and Analytics
Sanofi


Bio: David is a physician with 10 years' clinical experience in primary and secondary care in the UK and Australia, as well as over 17 years as a pharmaceutical physician with a specific interest in the medical role in health policy and market access. David has provided medical leadership in numerous launch teams, lead successful HTA submissions and has a wide therapeutic experience. In addition to 12 years of medical roles including regional and affiliate level leadership roles, he has also roles in as Head of HEOR for Global R&D AstraZeneca as well as Global Head of Government Affairs in AZ. In addition to his medical degree, David is also a Masters graduate in Heath Economics and Evidence-Based Medicine. David joined Sanofi in 2015 as Medical Director and then Country Medical Chair in the UK & Ireland, and since April 2016 has been Global Head of Medical Education and Scientific Communications reporting to Dr Sandra Silvestri in GEM. He has been married to Ruth for 25 years and they have two sons: Felix and Seth.

Christopher Winchester

Managing Director
Oxford PharmaGenesis Ltd


Type of Company:
Communications Agency
Professional Degrees: BA/BS, PhD

Bio: Chris Winchester is Managing Director of Oxford PharmaGenesis, an independent HealthScience communications consultancy with a strong heritage in publications. Now in its 20th year, Oxford PharmaGenesis employs over 200 communications professionals in Europe, North America and Asia Pacific. Chris is Chair Elect of ISMPP, led the development of the AMWA-EMWA-ISMPP Joint Position Statement on the role of the professional medical writer, and has been involved in collaborative research on the value of professional medical writing support. He has a doctorate in Biochemistry, has co-authored articles in the fields of cardiology, gastroenterology and respiratory medicine, and is an Associate Member of Green Templeton College, Oxford.

Karen Woolley

Director, Global Strategic Initiatives - Medical Affairs
ProScribe - Envision Pharma Group


Type of Company:
Communications Agency
Professional Degrees: CMPP, PhD
CMPP Certified: (3/2010)

Bio: Professor Karen Woolley is Certified Medical Publication Professional. She has 25 years of experience in the healthcare sector, gained in academia, hospital, industry, and agency environments in North America and the Asia Pacific region. She has led international teams to conduct and publish research on publication ethics and on patient engagement in evidence generation and communication. In 2000, Karen co-founded the Asia Pacific medical communication agency, ProScribe, which is proudly part of the global Envision Pharma Group. She has a strong focus on strategic initiatives in the medical affairs sector and leads teams in Envision's Tokyo and Sydney offices. Karen has served on ISMPP's Board of Trustees, chaired ISMPPs Asia Pacific Advisory Committee, and co-authored the Good Publication Practice 3 guidelines and the Joint Position Statement on Professional Medical Writers. She is an Honorary Fellow of AMWA, a Life Member of ARCS, and initiated the Global Alliance of Publication Professionals. She is a Professor at two universities and has been a government-appointed director overseeing 6 hospitals, serving on the Patient Safety and Quality Committee, and managing a $2B budget.

Mary Yianni

Senior Editor, Expert Reviews
Taylor and Francis Group


Type of Company:
Publisher
Other Degrees*: Msc

Bio: Mary is the Publisher of the Expert Collection journals published by Taylor & Francis and has worked on the series for the last 8 years. The Expert Collection combines the popular Expert Review and Expert Opinion journals and Mary oversees a team of the in house commissioning editors running the journals based in London. Her role is to support the ongoing editorial development of the journals, ensuring that we adhere to all ethical guidelines and publish the highest quality content for our readers. Mary is also responsible for finding the most relevant journal for content being submitted to the Expert Collection by medical communication and pharmaceutical companies, as well as academics and for ensuring that accelerated publication timelines are always met.
<< first < Prev 1 2 3 Next > last >>